High dose systemic methotrexate-associated acute neurologic dysfunction
β Scribed by Packer, Roger J. ;Grossman, Robert I. ;Belasco, Jean Bello
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 319 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
β¦ Synopsis
Two patients treated with high dose methof symptoms. Computed tomography in one otrexate with citrovorum rescue (HDMTX-CF) child disclosed a large low absorption abnorfor osteogenic sarcoma developed the acute mality. This patient represents the first reonset of neurologic deficits. Prior to the onset ported case of positive radiologic findings of symptoms, one child suffered brief epi-associated with this syndrome. The two pasodes of altered consciousness. Both patients tients recovered completely and received furdeveloped hemiparesis and then steadily im-ther HDMTX-CF without sequelae. This proved over 72 hours. Laboratory evaluations condition may result from transient demyelidisclosed normal coagulation parameters and nation or embolic cerebrovascular disease. nontoxic serum methotrexate levels at onset
π SIMILAR VOLUMES
Two patients, aged 24 and 19 years, who had undifferentiated lymphoma, developed the acute onset of focal neurologic deficits 10 days after treatment with moderate-dose methotrexate (2.76 g/m2 by 42-hour intravenous infusion) and 12.5 mg of intrathecal methotrexate. Prior chemotherapy also included
## Abstract We report an unusual case of anaphylaxis and hepatitic dysfunction in a child with the administration of the twentyβthird course of highβdose methotrexate. The latter had been used as an adjuvant to prevent pulmonary metastases and the prior 22 courses had been well tolerated. An attemp